Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin.
This intradermal vaccine delivery route is less invasive and will require a lesser dosage as well. The inactive virus-based vaccine is also being tested to be delivered in the intramuscular way.
Currently, the indigenously built vaccine is in phase II trials.
Cuttack: Odisha cricketer Sushree Dibyadarshini has been selected by the All-India Women’s Selection Committee to participate in the Targeted Women’s...
New Delhi: Social media platform X was down for tens of thousands of global users on Monday. The widespread technical...
Bhubaneswar: Odisha’s talented swimmer Mannata Mishra continued her remarkable ascent on the national stage by clinching a bronze medal in Women’s...
Bhubaneswar: Odisha’s top men’s tennis player Kabir Hans emerged singles champion with ease in the Rs 1 lakh AITA tournament...
Copyright © 2026 Frontier Media
